First Quarter 2023 Unaudited Financial Results
Total revenues were RMB178.7 million (US$26.0 million), compared with RMB342.6 million in the same period of 2022. This change was primarily due to the Company's continued strategy to refine its product selection across all categories and optimize its selection of suppliers and merchants, which had a near-term impact on sales.
Revenues from sales of merchandise were RMB143.0 million (US$20.8 million), compared with RMB290.5 million in the same period of 2022.
Revenues from the marketplace business were RMB32.9 million (US$4.8 million), compared with RMB47.4 million in the same period of 2022.
Other revenues were RMB2.8 million (US$0.4 million), compared with RMB4.7 million in the same period of 2022.
Recent YJ News
- Yunji Files 2023 Annual Report on Form 20-F • PR Newswire (US) • 04/25/2024 11:00:00 AM
- Yunji Receives Approval to Transfer to Nasdaq Capital Market • PR Newswire (US) • 04/04/2024 12:00:00 PM
- Yunji Announces Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results • PR Newswire (US) • 03/21/2024 10:00:00 AM
- Yunji to Report Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024 • PR Newswire (US) • 03/14/2024 11:00:00 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 11:08:58 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/06/2024 02:14:56 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/02/2024 11:08:27 AM
- Yunji Announces Appointment of New Independent Director • PR Newswire (US) • 01/01/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/14/2023 09:03:57 PM
- Yunji Announces Third Quarter 2023 Unaudited Financial Results • PR Newswire (US) • 12/14/2023 11:00:00 AM
- Yunji to Report Third Quarter 2023 Financial Results on December 14, 2023 • PR Newswire (US) • 12/06/2023 11:00:00 AM
- Yunji Announces Receipt of Nasdaq Notice • PR Newswire (US) • 10/09/2023 11:00:00 AM
- Yunji Announces Changes to Board Composition • PR Newswire (US) • 09/06/2023 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/06/2023 10:05:58 AM
- ADRs End Higher; Akso Health Group Climbs 33.6% • Dow Jones News • 08/25/2023 09:10:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/24/2023 08:08:07 PM
- Yunji Announces Second Quarter 2023 Unaudited Financial Results • PR Newswire (US) • 08/24/2023 10:00:00 AM
- Yunji to Report Second Quarter 2023 Financial Results on August 24, 2023 • PR Newswire (US) • 08/17/2023 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/07/2023 10:14:59 AM
- Yunji Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement • PR Newswire (US) • 07/07/2023 10:00:00 AM
- Yunji Announces Plan to Implement ADS Ratio Change • PR Newswire (US) • 06/12/2023 11:00:00 AM
- Yunji Announces First Quarter 2023 Unaudited Financial Results • PR Newswire (US) • 06/02/2023 10:00:00 AM
- Yunji to Report First Quarter 2023 Financial Results on June 2, 2023 • PR Newswire (US) • 05/25/2023 11:00:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM